Brief: Edgewise Therapeutics Q3 Operating Expenses USD 46.858 Million
06/11/2025 13:00
Nov 06 (Reuters) - Edgewise Therapeutics Q3 operating income USD -46.858 million. Q3 basic EPS USD -0.39 Q3 net income USD -40.666 million
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending